期刊文献+

MTBDR plus方法快速检测北京地区临床结核分枝杆菌分离株利福平和异烟肼耐药性效果评价 被引量:26

Evaluation on the MTBDRplus assay for rapid detection of resistance to rifampin and isoniazid in Mycobacterium tuberculosis Clinical isolates in Beijing
下载PDF
导出
摘要 目的评估MTBDR plus试剂盒在北京地区快速检测利福平和异烟肼的耐药性的效果。方法筛选169例临床结核分枝杆菌分离株,以国际标准的比例法作为对照,探讨该试剂盒在临床上应用的敏感性和特异性以及突变分布频率。结果在北京地区使用MTBDR plus检测利福平和异烟肼的敏感性和特异性分别为96.9%、85.3%和93.2%、98.1%。rpoB基因频率最高的突变位点是S531L(55.2%),其次是D516V(8.3%)、H526Y(7.3%)和H526D(3.1%)。katG基因频率最高的突变位点是S315T1(62.9%),而inhA是C15T位点(21.6%)。结论 MTBDR plus是一个敏感、特异和快速的诊断利福平、异烟肼耐药性和MDR的有效方法。 Objective To evaluate the effect of MTBDRplus assay in rapid detection of resistance to rifampin (RIF) and isoniazid (INH) in Mycobacterium tuberculosis clinical isolates collected in Beijing. Methods A total of 169 clinical isolates were enrolled in the study. Using the tranditional drug susceptibility testing as the control, the sensitivity and specificity of the MTBDRplus assay and the variety of gene mutations were assessed. Results The sensitivity and specificity of MTBDRplus assay for the detection of RIF and INH resistance were 96.9%, 85.3% and 93.2%, 98. 1%, respectively. The S531L mutation of rpoB was the most frequent (55.2%), followed by mutations D516V (8.3%), H526Y (7.3%) and H526D (3.1%). The frequent mutations of katG gene and inhA promoter region were S315T1 (62.9%) and C15T (21.6%) in INH-resistant isolates, respectively. Conclusion The MTBDRplus assay is a sensitive, specific and rapid tool for the diagnosis of RIF, INH resistance and multi-drug resistance in clinical isolates.
出处 《中国防痨杂志》 CAS 2010年第10期611-614,共4页 Chinese Journal of Antituberculosis
关键词 分枝杆菌 结核 抗药性 细菌 微生物敏感性试验 利福平 异烟肼 Mycobacterium tuberculosis drug-resistance, bacterial microbial sensitivity tests rifampin isoniazid
  • 相关文献

参考文献8

  • 1Vladyslav Nikolayevskyy, Yanina Balabanova, Tatyana Simak, Nadezhda Malomanova, Ivan Fedorin, Francis Drobniewski. Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation[J]. BMC Clinical Pathology, 2009, 9:2.
  • 2中国防痨协会基础专业委员会.结核病诊断实验室检验规程[S].北京:中国教育文化出版社,2006:30-37.
  • 3桂晓虹,徐鹏,赵明,王莉莉,武洁,李静,高谦,梅建.耐多药结核病快速诊断试剂盒检测耐药结核分枝杆菌的评价[J].中华结核和呼吸杂志,2010,33(1):43-45. 被引量:17
  • 4Freddie Bwanga, Sven Hoffner, Melles Haile, Moses L Joloba. Direct susceptibility testing for multi drug resistant tubereulosis: A meta-analysis[J]. BMC Infect Dis, 2009, 9: 67.
  • 5Paolo Miotto, Nuccia Saleri, Mathurin Dembele, Martial Ouedraogo, Gisele Badoum, Gabriele Pinsi, Giovanni B Migliori, Alberto Matteelli, Daniela M Cirillo. Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso[J]. BMC Infect Dis, 2009, 9.. 142.
  • 6Doris Hillemann, Sabine Rusch-Gerdes, Elvira Richter. Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical Specimens[J]. J Clin Microbiol, 2007, 45(8):2635-2640.
  • 7刘佳文,申阿东,孙桂芝.耐异烟肼结核分枝杆菌临床分离株耐药基因突变及其分子流行病学调查研究[J].临床肺科杂志,2007,12(6):567-569. 被引量:4
  • 8A Lacoma, N Garcia-Sierra, C Prat, J Ruiz-Manzano, L Haba, S Ros6s, J Maldonado, J Dominguez. GenoType MTBDRplus Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Strains and Clinical Samples [J]. J Clin Microbiol, 2008, 46(11): 3660-3667.

二级参考文献19

  • 1陈曦,马玙,金奇,姜广路,李传友,王庆.耐异烟肼结核分枝杆菌临床分离株耐药相关基因突变研究[J].中华结核和呼吸杂志,2005,28(4):250-253. 被引量:44
  • 2沈国妙,查佳,徐琳,孙斌,桂晓红,王奕峰,梅建,高谦.结核分枝杆菌散在分布重复单位基因型分型法的应用研究[J].中华结核和呼吸杂志,2005,28(5):292-296. 被引量:28
  • 3郭艳玲,王甦民,李传友,刘洋.IS6110限制性片段长度多态性和间隔区寡核苷酸分型技术在结核分枝杆菌菌株鉴定中的应用[J].中华检验医学杂志,2005,28(8):796-798. 被引量:4
  • 4中国防痨协会基础专业委员会.结核病诊断实验室检验规程.中国教育文化出版社.2006.
  • 5Parsons LM, Somoskovi A, Urbanczik R, et al. Laboratory diagnostic aspects of drug resistant tuberculosis. Front Biosci, 2004,9:2086-2105.
  • 6Piersimoni C, Olivieri A, Benacchio L, et al. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J Clin Microbiol, 2006,44:20-28.
  • 7Lacoma A, Garcia-Sierra N, Prat C, et al. GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol, 2008,46:3660-3667.
  • 8Hillemann D, Riisch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol, 2007,45:2635-2640.
  • 9Akpaka PE, Baboolal S, Clarke D, et al. Evaluation of methods for rapid detection of resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates collected in the Caribbean. J Clin Mierobiol, 2008,46:3426-3428.
  • 10Morlock GP, Metchock B, Sikes D, et al. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother, 2003,47:3799-3805.

共引文献32

同被引文献198

引证文献26

二级引证文献154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部